Immunocore Ownership | Who Owns Immunocore?

Overview Forecast RevenueFinancials Chart Transcripts

Immunocore Ownership Summary

Immunocore is owned by 90.46% institutional investors, 5.24% insiders, and 4.31% retail investors. Wellington management group llp is the largest institutional shareholder, holding 12.79% of IMCR shares. Vanguard Health Care Inv is the top mutual fund, with 9.16% of its assets in Immunocore shares.

IMCR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Immunocore	90.46%	5.24%	4.31%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Wellington management group llp	6.38M	12.79%	$216.23M
Rtw investments, lp	4.87M	9.76%	$165.04M
Fmr	4.81M	9.65%	$163.10M
T. rowe price investment management	2.99M	6.00%	$101.41M
Price t rowe associates inc /md/	2.83M	5.68%	$96.00M
Primecap management co/ca/	1.95M	3.91%	$66.12M
Baker bros. advisors lp	1.52M	3.04%	$51.35M
General atlantic	1.26M	2.53%	$42.76M
Bellevue group	1.15M	2.31%	$39.13M
Armistice capital	976.00K	1.96%	$33.08M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rtw investments, lp	4.87M	2.56%	$165.04M
Cantor fitzgerald, l. p.	254.03K	1.70%	$8.61M
Tang capital management	405.60K	1.40%	$13.75M
General atlantic	1.26M	1.34%	$42.76M
Baker bros. advisors lp	1.52M	0.66%	$51.35M
Bellevue group	1.15M	0.64%	$39.13M
Healthinvest partners ab	23.78K	0.49%	$805.84K
Armistice capital	976.00K	0.42%	$33.08M
Pier capital	81.31K	0.41%	$2.76M
Avidity partners management lp	200.00K	0.29%	$6.78M

Top Buyers

Holder	Shares	% Assets	Change
T. rowe price investment management	2.99M	0.06%	2.26M
Primecap management co/ca/	1.95M	0.05%	1.90M
Armistice capital	976.00K	0.42%	812.00K
Wellington management group llp	6.38M	0.04%	633.18K
Fmr	4.81M	0.01%	500.46K

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	-	-	-1.79M
Rtw investments, lp	4.87M	2.56%	-1.15M
Logos global management lp	-	-	-900.00K
Braidwell lp	-	-	-797.27K
Pictet asset management sa	-	-	-706.61K

New Positions

Holder	Shares	% Assets	Change	Value
Cantor fitzgerald, l. p.	254.03K	1.70%	254.03K	$8.61M
Hudson bay capital management lp	193.18K	0.03%	193.18K	$6.55M
Frazier life sciences management	108.76K	0.17%	108.76K	$3.69M
Engineers gate manager lp	38.18K	0.03%	38.18K	$1.29M
Ubs oconnor	30.00K	0.01%	30.00K	$94.50K

Sold Out

Holder	Change
Geneos wealth management	-11.00
Cva family office	-22.00
Newedge advisors	-90.00
Farther finance advisors	-99.00
Ashton thomas private wealth	-168.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	138	-6.76%	45,248,455	3.71%	90	1.18%	64	-23.81%	37	15.63%
Jun 30, 2024	145	-9.94%	43,628,132	5.90%	87	1231365.60%	82	-9.89%	31	-27.91%
Mar 31, 2024	161	10.27%	41,196,539	9.88%	-	0.00%	91	15.19%	43	2.38%
Dec 31, 2023	146	11.45%	37,492,758	1.55%	76	1.33%	79	25.40%	42	5.00%
Sep 30, 2023	131	4.80%	36,920,468	4.59%	75	1.41%	63	-19.23%	40	53.85%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	4.58M	9.16%	733.57K
T. Rowe Price US Small-Cap Core Equity	1.82M	3.64%	1.09M
T. Rowe Price Small-Cap Stock	1.82M	3.64%	406.88K
Vanguard Capital Opportunity Inv	1.62M	3.24%	427.17K
BB Biotech AG Ord	1.21M	2.41%	57.41K
Fidelity Growth Compy Commingled Pl S	1.16M	2.32%	8.79K
Fidelity Growth Compy Commingled Pl O	1.15M	2.30%	101.00
T. Rowe Price Small-Cap Value	1.12M	2.25%	177.80K
T. Rowe Price Health Sciences	1.12M	2.23%	-107.86K
T. Rowe Price Instl Small-Cap Stock	902.83K	1.80%	205.22K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 01, 2024	St Leger Tina Amber	CHIEF HR OFFICER	Sell	$280.26K
Feb 28, 2024	Berman David M	HEAD OF R&D	Sell	$514.37K
Feb 28, 2024	Berman David M	HEAD OF R&D	Sell	$762.64K
Feb 28, 2024	Berman David M	HEAD OF R&D	Sell	$84.54K
Feb 28, 2024	Berman David M	HEAD OF R&D	Sell	$1.14M

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	1
2024 Q1	-	12

IMCR Ownership FAQ

Who Owns Immunocore?

Immunocore shareholders are primarily institutional investors at 90.46%, followed by 5.24% insiders and 4.30% retail investors. The average institutional ownership in Immunocore's industry, Biotech Stocks , is 47.04%, which Immunocore exceeds.

Who owns the most shares of Immunocore?

Immunocore’s largest shareholders are Wellington management group llp (6.38M shares, 12.79%), Rtw investments, lp (4.87M shares, 9.76%), and Fmr (4.81M shares, 9.65%). Together, they hold 32.20% of Immunocore’s total shares outstanding.

Does Blackrock own Immunocore?

BlackRock is not among the top 10 institutional shareholders of Immunocore.

Who is Immunocore’s biggest shareholder by percentage of total assets invested?

Rtw investments, lp is Immunocore’s biggest shareholder by percentage of total assets invested, with 2.56% of its assets in 4.87M Immunocore shares, valued at 165.04M$.

Who is the top mutual fund holder of Immunocore shares?

Vanguard Health Care Inv is the top mutual fund holder of Immunocore shares, with 9.16% of its total shares outstanding invested in 4.58M Immunocore shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools